...
首页> 外文期刊>Neuropharmacology >Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
【24h】

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

机译:油酰胺对大鼠体内5-HT 2受体介导的行为的修饰和大麻素受体的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Oleamide (cis-9,10-octadecenoamide) is an endogenous brain lipid which has been suggested to induce sleep in experimental animals. The mechanism of action is unclear but shares many of the characteristics of endogenous cannabinoids such as anandamide and has been shown to enhance in vitro responses to 5-HT and GABA. In the present study we investigated the effects of oleamide on two motor behaviours, back muscle contractions (BMC) and wet-dog shakes (WDS) induced in rats by treatment with the 5-HT2 receptor agonist DOI ((+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride). We then examined the potential involvement of CB1 cannabinoid receptors in the responses to oleamide and the mechanism of interaction between CB1 and 5-HT2 receptors. Oleamide and the cannabinoid receptor agonist HU210 (6aR)-trans-3-(1,1-dimethylheptyl)6a,7,10,10a-tetrahydro-1-h ydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol) produced a hypolocomotion which was prevented by the CB1 antagonist SR141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-me thyl-1H-pyrazole-3-carboxamide hydrochloride). Despite having no effect alone, oleamide and HU210 potentiated BMC induced by treatment with DOI. SR141716A alone did not affect the response to DOI but it blocked the potentiations caused by oleamide or HU210. WDS were unaffected by oleamide and slightly reduced by HU210. In vitro, oleamide and HU210 enhanced the high affinity binding of 5-HT to 5-HT2 receptors on rat cerebral cortex membranes labelled with 3H-ketanserin. Neither agent, however, altered 5-HT-stimulated phosphoinositide hydrolysis in rat cerebral cortex slices. Oleamide occupied CB1 cannabinoid receptors on rat brain membranes labelled with 3H-CP55940 with an IC50 of 10 microM. The data presented are consistent with oleamide acting via a cannabinoid recognition site to enhance 5-HT2 receptor function in vivo. The mechanism of the modulation is still unclear but it does not appear to involve a potentiation of 5-HT2 receptor-stimulated phosphoinositide hydrolysis.
机译:油酰胺(顺式9,10-十八烯酰胺)是一种内源性脑脂质,已被认为可诱导实验动物睡眠。作用机理尚不清楚,但具有内源性大麻素(如anandamide)的许多特征,并且已显示出可增强对5-HT和GABA的体外反应。在本研究中,我们研究了油酰胺对大鼠5-HT2受体激动剂DOI((+/-)-1)引起的两种运动行为,背部肌肉收缩(BMC)和湿狗震动(WDS)的影响。 -(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷盐酸盐)。然后,我们检查了CB1大麻素受体对油酰胺的反应以及CB1和5-HT2受体之间相互作用的机制的潜在参与。油酰胺和大麻素受体激动剂HU210(6aR)-trans-3-(1,1-二甲基庚基)6a,7,10,10a-四氢-1-h羟基-6,6-二甲基-6H-二苯并[b,d ] pyran-9-甲醇)产生低运动,这被CB1拮抗剂SR141716A(N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-me阻止1H-吡唑-3-甲酰胺盐酸盐)。尽管单独没有作用,但是油酰胺和HU210增强了用DOI处理诱导的BMC。单独使用SR141716A并不会影响对DOI的反应,但会阻止油酰胺或HU210引起的增强作用。 WDS不受油酰胺影响,受HU210轻微降低。在体外,油酰胺和HU210增强了3HT-酮色林标记的大鼠大脑皮层膜上5-HT与5-HT2受体的高亲和力结合。但是,这两种药物均未改变大鼠大脑皮层切片中5-HT刺激的磷酸肌醇水解。油酰胺在大鼠脑膜上占据了标记为3H-CP55940的CB1大麻素受体,IC50为10 microM。呈现的数据与通过大麻素识别位点发挥作用以增强体内5-HT2受体功能的油酰胺相一致。调节的机制仍不清楚,但似乎不涉及5-HT 2受体刺激的磷酸肌醇水解的增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号